WH-4-023 5 mg | Purity Not Available
TargetMol

WH-4-023 is a potent and orally active Lck/Src inhibitor. It also potently inhibits SIK.
More Information Supplier PageWH-4-023 is a potent and orally active Lck/Src inhibitor. It also potently inhibits SIK.
More Information Supplier PageDapivirine is a diarylpyrimidine non-nucleoside reverse transcriptase inhibitor.
More Information Supplier PageXMD17-109 is a new selective ERK-5 inhibitor (EC50: 4.2 uM, HEK293 cells).
More Information Supplier PageReversine, a small synthetic purine analogue (2, 6-disubstituted purine), is a potent inhibitior of Aurora A/B/C(IC50s=150-500 nM).
More Information Supplier PageReversine, a small synthetic purine analogue (2, 6-disubstituted purine), is a potent inhibitior of Aurora A/B/C(IC50s=150-500 nM).
More Information Supplier PageReversine, a small synthetic purine analogue (2, 6-disubstituted purine), is a potent inhibitior of Aurora A/B/C(IC50s=150-500 nM).
More Information Supplier PageReversine, a small synthetic purine analogue (2, 6-disubstituted purine), is a potent inhibitior of Aurora A/B/C(IC50s=150-500 nM).
More Information Supplier PageDapivirine is a diarylpyrimidine non-nucleoside reverse transcriptase inhibitor.
More Information Supplier PageDapivirine is a diarylpyrimidine non-nucleoside reverse transcriptase inhibitor.
More Information Supplier PageCarfilzomib is an irreversible proteasome inhibitor and antineoplastic agent that is used in treatment of refractory multiple myeloma.
More Information Supplier Page